Related references
Note: Only part of the references are listed.Copeptin for the early rule-out of non-ST-elevation myocardial infarction
Kris G. Vargas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
Olga Barbarash et al.
ANNALS OF LABORATORY MEDICINE (2016)
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction
Michelle L. O'Donoghue et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
ST2 and Patient Prognosis in Chronic Heart Failure
Antoni Bayes-Genis et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
ST2 in Stable and Unstable Ischemic Heart Diseases
A. Mark Richards et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure
Susan E. Piper et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention
Jeonggeun Moon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis
Tatiana Raskovalova et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2014)
Pre-discharge risk stratification in unselected STEMI: Is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?
Onkar S. Dhillon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
High-Sensitivity C-Reactive Protein and Cardiovascular Disease A Resolute Belief or an Elusive Link?
Omair Yousuf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction Evidence From a Comprehensive Network Meta-Analysis
Tullio Palmerini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial
Payal Kohli et al.
CLINICAL CHEMISTRY (2012)
Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP
Onkar S. Dhillon et al.
AMERICAN HEART JOURNAL (2011)
Biomarkers in acute myocardial infarction
Daniel Chan et al.
BMC MEDICINE (2010)
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial
Benjamin M. Scirica et al.
EUROPEAN HEART JOURNAL (2010)
The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all corners (n=6129)
Joost Daemen et al.
EUROINTERVENTION (2009)
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Marc S. Sabatine et al.
CIRCULATION (2008)
Serum Soluble ST2 as a Biochemical Marker of Acute Heart Failure Future Areas of Research
Javier Diez
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Shafiq U. Rehman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
M Shimpo et al.
CIRCULATION (2004)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
EO Weinberg et al.
CIRCULATION (2002)
Elevations in troponin T and I are associated with abnormal tissue level perfusion - A TACTICS-TIMI 18 substudy
GC Wong et al.
CIRCULATION (2002)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.
B Lindahl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
